Adcitmer

N/A

Report date: 2024/02/05 14:00:20

Base Information

Drug NameAdcitmer

Drug Alias NameAdcitmer

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Linker > Cleavable linkerBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Payload > MMAE payloadBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)

Mechanisms of ActionAnti-NCAM1

TargetsNeural cell adhesion molecule 1

Therapy Area/IndicationsCarcinoma, Merkel Cell

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryFrance

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesUniversity Of Tours

China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Tours

Inactive CompaniesN/A

Active IndicationsCarcinoma, Merkel Cell

Inactive IndicationsN/A

Other Information

ATC CodeN/A